Transwell invasion assays showed that knockdown of PTPN12, YTHDC2, and MAPKAPK3, as well as overexpression of GPX3, RASA3, and TSPAN4, significantly inhibited the invasive capacity of DCIS cells (Figure 11A,C,D). Here, PTPN12 is linked to ductal breast carcinoma in situ.